Patents by Inventor Bengt Agerup
Bengt Agerup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230211051Abstract: Particles made of a viscoelastic medium, are injectable gel particles, and have a size, when subjected to a physiological salt solution, in the range of from 1 to 5 mm. The particles are useful in a soft tissue augmentation implant. The implant includes particles of a viscoelastic medium, wherein a major volume of the particles are injectable gel particles The implant is useful in a method of soft tissue augmentation in a mammal, including man, comprising subepidermal administration at a site in said mammal where soft tissue augmentation is desirable, of an implant.Type: ApplicationFiled: September 9, 2022Publication date: July 6, 2023Applicant: Galderma Holding SAInventor: Bengt Agerup
-
Publication number: 20200030494Abstract: Particles made of a viscoelastic medium, are injectable gel particles, and have a size, when subjected to a physiological salt solution, in the range of from 1 to 5 mm. The particles are useful in a soft tissue augmentation implant. The implant includes particles of a viscoelastic medium, wherein a major volume of the particles are injectable gel particles The implant is useful in a method of soft tissue augmentation in a mammal, including man, comprising subepidermal administration at a site in said mammal where soft tissue augmentation is desirable, of an implant.Type: ApplicationFiled: October 4, 2019Publication date: January 30, 2020Applicant: NESTLÉ SKIN HEALTH S.A.Inventor: Bengt ÅGERUP
-
Publication number: 20180093017Abstract: Particles made of a viscoelastic medium, are injectable gel particles, and have a size, when subjected to a physiological salt solution, in the range of from 1 to 5 mm. The particles are useful in a soft tissue augmentation implant. The implant includes particles of a viscoelastic medium, wherein a major volume of the particles are injectable gel particles The implant is useful in a method of soft tissue augmentation in a mammal, including man, comprising subepidermal administration at a site in said mammal where soft tissue augmentation is desirable, of an implant.Type: ApplicationFiled: November 2, 2017Publication date: April 5, 2018Applicant: Q-Med ABInventor: Bengt Ågerup
-
Publication number: 20140147479Abstract: Particles according to the invention are made of a viscoelastic medium, are injectable gel particles, and have a size, when subjected to a physiological salt solution, in the range of from 1 to 5 mm. The particles are useful in a soft tissue augmentation implant. The implant comprises particles of a viscoelastic medium, wherein a major volume of the particles are injectable gel particles according to the invention. The implant is useful in a method of soft tissue augmentation in a mammal, including man, comprising subepidermal administration at a site in said mammal where soft tissue augmentation is desirable, of an implant according to the invention.Type: ApplicationFiled: January 31, 2014Publication date: May 29, 2014Applicant: Q-Med ABInventor: Bengt AGERUP
-
Patent number: 7942930Abstract: The invention relates to an implantable combination comprising a barrier (12), and a macromolecular bio-compatible material (14). The barrier (12) is porous to allow moieties of the macromolecular bio-compatible material (14), when implanted, to be exposed through the barrier, whereby the surface of the barrier is experienced by the body as an essentially non-foreign object. It also relates to an implant made from a barrier material and a bio-compatible material, the implant being suitable as e.g. a breast implant.Type: GrantFiled: June 15, 2007Date of Patent: May 17, 2011Assignee: Q-Med ABInventors: Bengt Agerup, Ninus Caram-Letham, Ulf Winter
-
Publication number: 20100279952Abstract: The invention relates to a biocompatible metastable intermediate material for controlling the mobility of at least one biologically active substance. An example of the invention is a hydrogel formed by cross-linked sodium hyaluronate treated with an oxidizing agent so as to open sugar rings and form aldehyde groups. The gel according to the invention is sterilized, e.g. by autoclaving.Type: ApplicationFiled: December 22, 2008Publication date: November 4, 2010Inventors: Ninus Caram-Lelham, Ulf Winter, Bengt Agerup
-
Publication number: 20080312739Abstract: The invention relates to an implantable combination comprising a barrier (12), and a macromolecular bio-compatible material (14). The barrier (12) is porous to allow moieties of the macromolecular bio-compatible material (14), when implanted, to be exposed through the barrier, whereby the surface of the barrier is experienced by the body as an essentially non-foreign object. It also relates to an implant made from a barrier material and a bio-compatible material, the implant being suitable as e.g. a breast implant.Type: ApplicationFiled: June 15, 2007Publication date: December 18, 2008Applicant: Q-Med ABInventors: Bengt Agerup, Ninus Caram-Lelham, Ulf Winter
-
Publication number: 20080058760Abstract: A viscoelastic medium is useful for the manufacture of a medicament, such as a medical device, for treatment of increased intraocular pressure in the eye of a human or animal. The medicament is administerable into at least one sclerally penetrating fistula of the eye such that the fistula is filled with the medicament. The medium is also useful in a method of treating increased intraocular pressure in the eye of a human or an animal in need thereof, comprising the step of injecting the viscoelastic medium into at least one sclerally penetrating fistula in the eye such that the fistula is filled with the medium.Type: ApplicationFiled: May 4, 2005Publication date: March 6, 2008Inventor: Bengt Agerup
-
Publication number: 20050226936Abstract: Particles according to the invention are made of a viscoelastic medium, are injectable gel particles, and have a size, when subjected to a physiological salt solution, in the range of from 1 to 5 mm. The particles are useful in a soft tissue augmentation implant. The implant comprises particles of a viscoelastic medium, wherein a major volume of the particles are injectable gel particles according to the invention. The implant is useful in a method of soft tissue augmentation in a mammal, including man, comprising subepidermal administration at a site in said mammal where soft tissue augmentation is desirable, of an implant according to the invention.Type: ApplicationFiled: March 28, 2005Publication date: October 13, 2005Applicant: Q-Med ABInventor: Bengt Agerup
-
Publication number: 20040267201Abstract: A medical pump, comprising a reservoir having a fluid enclosing portion and a tubular element, the inside of which is arrangeable in fluid communication with the fluid enclosing portion for allowing fluid to pass into the tubular element. The fluid enclosing portion contains a volume of fluid sealed from communication with air and the fluid enclosing portion is adapted to reduce in volume essentially to the same extent as any volume of fluid transferred into the inside of the tubular element. The invention also relates to a method of delivering a medical fluid.Type: ApplicationFiled: June 19, 2003Publication date: December 30, 2004Inventor: Bengt Agerup
-
Publication number: 20030176840Abstract: The present invention relates to an arrangement and a method for interacting with an internal body organ. The arrangement comprises a sheath in which at least two elongate structural elements are inserted. The structural elements each have a proximal end and a distal end. The sheath has a proximal end and a distal end, said distal end being open. When the structural elements are displaced relative to the sheath they extend through the open distal end of the sheath and at least partly in the transverse direction away from the sheath for distending and/or expanding interaction between the distal end of each structural element and a body organ.Type: ApplicationFiled: December 31, 2002Publication date: September 18, 2003Inventor: Bengt Agerup
-
Patent number: 5128341Abstract: The present invention relates to a novel use of .beta.-receptor blocking agents for preparation of a drug for treatment of Meniere's disease.Type: GrantFiled: March 29, 1991Date of Patent: July 7, 1992Assignee: Bengt AgerupInventors: Bengt Agerup, Fredrik Aust